• Bacteriophage therapeutics market Research Report by 2022, Forecast till 2035

    With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases.

    One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.

    The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:
     Type of Therapeutic Area
     Infectious Diseases
     Oncological Disorders
     Other Disorders
     Distribution by Route of Administration
     Oral Route
     Rectal Route
     Intravesical Route
     Topical Route

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Latin America
     Middle East and North Africa

    The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:
     Adaptive Phage Therapeutics
     ContaFect
     Eliava BioPreparations
     Micreos
     NPO Microgen
     Phagelux
     Pherecydes Pharma

    Table of Content

    1. PREFACE

    2. EXECUTIVE SUMMARY

    3. INTRODUCTION

    4. BACTERIOPHAGE THERAPY: MARKET LANDSCAPE

    5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE

    6. COMPANY AND DRUG PROFILES

    7. CLINICAL TRIAL ANALYSIS

    8. PATENT ANALYSIS

    9. PUBLICATION BENCHMARKING ANALYSIS

    10. ACADEMIC GRANTS ANALYSIS

    11. FUNDING AND INVESTMENT ANALYSIS

    12. PARTNERSHIPS AND COLLABORATIONS

    13. START-UP HEALTH INDEXING

    14. MARKET FORECAST AND OPPORTUNITY ANALYSIS

    15. CONCLUSION

    16. EXECUTIVE INSIGHTS

    17. APPENDIX I: TABULATED DATA

    18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
    For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html

    You may also be interested in the following titles:
    Pharmaceutical Polymers / Medical Polymers Market

    Gene Switch Market


    You may also like to learn what our experts are sharing in Roots educational series:
    T-cell Immunotherapies: The Future of Modern Cancer Treatments

    Monkeypox: Disease Overview, Transmission and Diagnosis


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #Bacteriophage therapeutics market #Bacteriophagetherapeuticsmarketsize #bacteriophagephage #bacteriophagetherapy



    Bacteriophage therapeutics market Research Report by 2022, Forecast till 2035 With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases. One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains. The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:  Type of Therapeutic Area  Infectious Diseases  Oncological Disorders  Other Disorders  Distribution by Route of Administration  Oral Route  Rectal Route  Intravesical Route  Topical Route  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:  Adaptive Phage Therapeutics  ContaFect  Eliava BioPreparations  Micreos  NPO Microgen  Phagelux  Pherecydes Pharma Table of Content 1. PREFACE 2. EXECUTIVE SUMMARY 3. INTRODUCTION 4. BACTERIOPHAGE THERAPY: MARKET LANDSCAPE 5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE 6. COMPANY AND DRUG PROFILES 7. CLINICAL TRIAL ANALYSIS 8. PATENT ANALYSIS 9. PUBLICATION BENCHMARKING ANALYSIS 10. ACADEMIC GRANTS ANALYSIS 11. FUNDING AND INVESTMENT ANALYSIS 12. PARTNERSHIPS AND COLLABORATIONS 13. START-UP HEALTH INDEXING 14. MARKET FORECAST AND OPPORTUNITY ANALYSIS 15. CONCLUSION 16. EXECUTIVE INSIGHTS 17. APPENDIX I: TABULATED DATA 18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html You may also be interested in the following titles: Pharmaceutical Polymers / Medical Polymers Market Gene Switch Market You may also like to learn what our experts are sharing in Roots educational series: T-cell Immunotherapies: The Future of Modern Cancer Treatments Monkeypox: Disease Overview, Transmission and Diagnosis About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Bacteriophage therapeutics market #Bacteriophagetherapeuticsmarketsize #bacteriophagephage #bacteriophagetherapy
    WWW.ROOTSANALYSIS.COM
    Bacteriophage Therapy Market Size, Share, Trends and Forecast (2035)
    The global bacteriophage therapy market is projected to grow from USD 74 million in 2022 to USD 193 million by 2035, exhibiting a CAGR of 8% during forecast period
    0 Comments 0 Shares
No data to show
No data to show
No data to show
No data to show
No data to show
Buy Crypto with VISA/MC
G-8F6Y62QLZ0